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Transforming growth factor-b (TGF-b) is a multifunctional polypeptide which plays a crucial role in the regulation of cell
proliferation, differentiation, and organogenesis. In the present study, we investigated the expression of signaling receptors
for TGF-b in developing mice by in situ hybridization, revealing a signi®cant difference in the expression of TGF-b type
I and type II receptors. Unexpectedly, the TGF-b type I receptors were exclusively expressed without any detectable
expression of the TGF-b type II receptors in developing cerebral cortices. In primary cortical neurons, a neutralizing
antibody for TGF-b signi®cantly reduced the expression of bcl-2 and subsequently induced neuronal cell death, indicating
that TGF-b functions as a survival factor for cortical neurons in vitro. Consistent with the result of in situ hybridization,
the TGF-b type I but not type II receptors were detected in primary cortical neurons by af®nity crosslink and RT±PCR
analyses. The concomitant expression of TGF-b2 and the TGF-b type I receptors in developing cerebral cortices suggests
that the TGF-b signaling system plays a pivotal role in neuronal differentiation and that unidenti®ed components may be
involved in TGF-b signaling in the development of the central nervous system. q 1996 Academic Press, Inc.
INTRODUCTION al., 1981; Roberts et al., 1981). TGF-b belongs to the mem-
ber of TGF-b superfamily (Sporn and Roberts, 1992) which
includes activin, inhibin, bone morphogenetic proteinTransforming growth factor-b (TGF-b)3 was initially puri-
(BMP), Mullerian inhibiting substance (MIS), and glial cell®ed and characterized as a 25-kDa homodimeric polypep-
line-derived neurotrophic factor (GDNF; Lin et al., 1993).tide on the basis of its ability to induce the growth of normal
Three isoforms, TGF-b1, -b2, and -b3, have so far been iden-rat kidney (NRK) ®broblasts in soft agar culture (Moses et
ti®ed in mammals (Kingsley, 1994). In an in vitro culture
system, TGF-bs have various biological activities including
1 Present address: The Rockefeller University, Laboratory of De- the regulation of cell growth and differentiation, the control
velopmental Neurobiology, 1230 York Ave., New York, NY 10021- of cell migration, the adhesiveness and invasiveness of tu-
6399. mor cells, and the regulation of extracellular matrix forma-2 To whom correspondence should be addressed. Fax: 81-3-3579- tion (Massague, 1990; Roberts and Sporn, 1990). The roles
4776; E-mail: sirasawa@tmig.or.jp.
of TGF-bs in vivo have also been suggested by their spatial3 Abbreviations used: TGF-b, transforming growth factor-b;
and temporal patterns of expression during murine develop-DRG, dorsal root ganglia; RT±PCR, reverse transcription±poly-
ment (Akhurst et al., 1990; Millan et al., 1991; Pelton etmerase chain reaction; NGF, nerve growth factor; BDNF, brain-
al., 1991; Schmid et al., 1991; Dickson et al., 1993).derived neurotrophic factor; NT-3, -4/5, neurotrophin-3, -4/5; MAP-
As to their receptors, TGF-bs interact mainly with dis-2, microtubule-associated protein-2; GFAP, glial ®brillary acidic
protein; CNS, central nervous system. tinct cell surface proteins known as receptors type I (53
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kDa), type II (75±80 kDa), and type III (250±300 kDa, also tion. Here we demonstrate that TGF-b could transduce a
survival signal by maintaining the expression of bcl-2 inknown as betaglycan; Massague, 1992). Activin binds to
pairs of membrane proteins that are similar in size to TGF- cultured cortical neurons in vitro in an autocrine or para-
crine manner. We also discuss the possible role of TGF-bb receptors type I and type II. Recently, TGF-b type II recep-
tor (Lin et al., 1992; Lawler et al., 1994; Suzuki et al., 1994), during neurogenesis and the possibility that the divergent
receptor components might be regulated in the develop-activin type II/IIb receptors (Mathews et al., 1991; Attisano
et al., 1992), TGF-b type I receptor (Franzen et al., 1993; He ment of the nervous system.
et al., 1993; Suzuki et al., 1994; Tomoda et al., 1994), and
activin type I/Ib receptors (Ebner et al., 1993; He et al.,
1993; Matsuzaki et al., 1993; ten Dijke et al., 1993; Carcamo
MATERIALS AND METHODSet al., 1994) have been molecularly cloned, revealing that
they constitute a family of transmembrane protein serine/
threonine kinases. Several lines of evidence showed that the Growth Factors and Neutralizing Antibody
type I and type II receptors of this family are the functional
Human recombinant TGF-b1 was purchased from King Brewingsignaling receptors in vitro and that the type I receptors
Co., LTD. (Japan), and porcine TGF-b2 from R&D Systems, Inc.generally require the type II receptors to bind their ligands,
(Minneapolis, MN). They were reconstituted in 4 mM HCl con-while the type II receptors require the type I receptors to
taining 1 mg/ml bovine serum albumin (BSA). Human activin Atransduce signals (Wrana et al., 1992; Attisano et al., 1993;
and human recombinant follistatin were generous gifts from Dr.
Franzen et al., 1993; Bassing et al., 1994; Wrana et al., 1994). Eto (Ajinomoto, Co., LTD.). Anti-rabbit anti-TGF-b1 and 2 antise-
It is therefore important to clarify how the type I and type rum was purchased from King Brewing Co., LTD. According to the
II receptors for TGF-b are coordinated in vivo to exert a wide data provided from the manufacturer, the speci®city of this anti-
range of biological responses and how their expressions are body has been con®rmed by the assay system as described by Rob-
erts et al. (1986). Two independent lots of neutralizing antibodydivergently regulated in vivo.
(lot R-03 and lot R-073 of Code 1100-NR from King Brewing Co.,In the nervous system, TGF-b1, but not TGF-b2, has been
LTD) had been tested to con®rm that they showed no toxic effectsshown to protect neurons from neuronal death induced by
on the primary cortical culture.hypoxia or excess of glutamate (Prehn et al., 1993). In a
coculture system of neurons and nonneuronal cells prepared
from dorsal root ganglia (DRG), TGF-b markedly increased
neuronal survival, particularly when nonneuronal cells In Situ Hybridization
were present (Chalazonitis et al., 1992). TGF-b1 also stimu-
Mouse embryos of Days 8, 10, 12, 14, 16, and 18 p.c. and mouselates the synthesis of nerve growth factor (NGF) in cultured
Day 3 neonatal tissues were ®xed in 4% paraformaldehyde in PBS atastrocytes in vitro and neonatal brains in vivo, and the ex-
47C overnight, dehydrated with ethanol, and embedded in paraf®n.pression of TGF-b1 is up-regulated in the cerebral cortex of
Serial sections were cut at 5 mm and mounted on poly-L-lysine-
a penetrating brain injury (Lindholm et al., 1992). In normal coated slides. After the removal of wax, sections were post®xed in
brains, however, TGF-b1 is expressed in a low amount 4% paraformaldehyde, treated with 0.25% acetic anhydrite in 0.1
(Flanders et al., 1991) and localizes in meningeal cells M triethanolamine, and dehydrated again. For the antisense probe
(Heine et al., 1987). On the other hand, TGF-b2, and -b3 of TGF-b type I receptor, pGEM7Z plasmid (Promega, Madison,
WI) harboring a 709-bp ApaI/SacI fragment (nt 1673±2382) ofare detectable in the central nervous system during early
mouse TGF-b type I receptor was linearized with ApaI and tran-mouse development (Flanders et al., 1991). Therefore,
scribed with SP6 polymerase according to manufacturer's condi-whether TGF-bs mediate trophic actions upon neurons un-
tions (Promega, Madison, WI) with [35S]UTP (1000 Ci/mmol01,der physiological conditions remained to be determined.
Amersham, UK). The sense probe of TGF-b type I receptor wasRecently, some members of TGF-b superfamily have been
synthesized by T7 polymerase after linearization with SacI. Forshown to be potent survival factors for midbrain dopaminer-
the antisense probe of TGF-b type II receptor, pGEM7Z plasmid
gic neurons in vitro (Poulsen et al., 1994; Krieglstein et (Promega, Madison, WI) harboring a 750-bp HindIII/EcoRV frag-
al., 1995). ment (nt 370±1120) of mouse TGF-b type II receptor (Gift from
In the present study, we analyzed the distribution of TGF- Dr. Ueno) was linearized with HindIII and transcribed with T7
b type I and type II receptors in the development of murine polymerase. The sense probe of TGF-b type II receptor was synthe-
sized by SP6 polymerase after linearization with EcoRI. Hybridiza-embryos and neonates by in situ hybridization and found
tions were performed at 507C for 16 hr in 50% deionized for-that these two components of TGF-b receptors were tran-
mamide, 10 mM Tris±HCl, pH 7.6, 1 mM EDTA, 600 mM NaCl,scriptionally regulated in a distinct manner during the de-
0.25% SDS, 11 Denhardt's solution, 10% dextran sulfate, 10 mMvelopment of various organs including brain, retina, and
DTT, 200 mg/ml Escherichia coli tRNA, and 1 1 107 cpm/ml radio-renal tissue. Interestingly, TGF-b type I receptor was exclu-
labeled probe. After hybridization, samples were treated with 12.5sively expressed in the developing brain and retina without
mg/ml RNase A at 377C for 30 min. Washing was performed in 0.11
any detectable expression of known TGF-b type II receptor. SSC at 507C. The slide were dehydrated with ethanol. Autoradiogra-
The fact that neonatal cortical neurons only express the phy was performed using Kodak NTB-3 emulsion diluted 1:1 with
type I receptor prompted us to investigate the signal trans- 2% glycerol in distilled water. After exposure, the slides were devel-
duction system of TGF-b in cultured cortical neurons with oped by Kodak D-19 and ®xed by Fuji®x. Sections were counter-
stained with hematoxylin and eosin (H&E) or toluidine blue.respect to its physiological function and receptor organiza-
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tracted from rat cultured cortical cells by the acid guanidiniumCell Culture
thiocyanate±phenol±chloroform (AGPC) method (Chomzynski et
Rat brain cortical cell culture was prepared as described pre- al., 1987). Ten micrograms of isolated RNA was resolved by electro-
viously (Ghosh et al., 1994). In brief, Day 16 p.c. rat embryos were phoresis in a 1.2% agarose± formaldehyde gel and blotted onto ny-
dissected and the cerebral cortex was removed. Tissues were enzy- lon membrane (Hybond N/, Amersham). As a probe, mouse bcl-2
matically dissociated with trypsin and collagenase, and the cells was labeled with [32P]dCTP by random priming (Sambrook et al.,
were seeded in Dulbecco's modi®ed Eagle's medium (DMEM) sup- 1989). Hybridization was performed in buffer containing 51 SSC,
plemented with 1 mM progesterone, 100 mM putrescine, 5 mg/ml 101 Denhardt's solution, 2% SDS, and 100 mg/ml denatured
insulin, 5 mg/ml transferrin, 5 mg/ml sodium selenite, and 20 ng/ salmon sperm DNA, at 657C for 16 hr, and blots were washed at
ml 3,3*,5-triiodo-L-thyronine, in a humidi®ed 5% CO2/95% air at- 657C in 0.51 SSC, 0.5% SDS, and exposed to XAR ®lm (Kodak) at
mosphere at 377C, at 1.5 1 107 cells/plate (100 mm diameter) or 0807C. Densitometric scanning of the autoradiograms was per-
1.5 1 105 cells/well in 96-well tissue culture plates. Half of the formed using a Fuji Image Analyzer (BAS 2000).
medium was replaced every 2±3 days. More than 98% of the pri-
mary culture cells prepared as above were positively stained by
anti-MAP-2 monoclonal antibody. The neuronal population was RT±PCR
con®rmed in all the experiments described in the paper. In our
preliminary experiments of low-density neuronal culture (5 1 106 Total RNA was extracted from rat cultured cortical cells by the
cells/100 mm plate or 5 1 104 cells/well in 96-well culture plates), AGPC method (Chomzynski et al., 1987). The RNA was reverse
we found that TGF-bs failed to affect neuronal survival any more transcribed by Superscript II reverse transcriptase (BRL) with an
than in high-density culture (Fig. 4A). Since both conditions yielded oligo(dT) primer followed by polymerase chain reaction (PCR). Oli-
essentially the same results, and also because the high-density con- gonucleotides used in PCR are as follows: primer 1, 5*-GAT TCC
dition yielded more consistent data in MTT assay with a lower ATA AAT ATG AAA CAT-3*; primer 2, 5*-CAT AAT TTT AGC
signal/noise ratio, all the neuronal culture experiments in the pres- CAT CAC TCT-3*; primer 3, 5*-TAC GAG GAG TAC TCC TCG
ent study were carried out in high-density culture conditions. TGG-3*; primer 4, 5*-AAT GGG CAT CTT GGG CCT CCC-3*;
primer 5: 5*-GAA ACC ATC CAA GTG GAT TGC-3*; primer 6,
5*-CAT CAG CTT CGC CAG AGA AGT-3*; primer 7, 5*-AAC
MTT Assay ATG AAG CAC TTT GAC TCC-3*; primer 8, 5*-CAT CAT CTT
TCC CAT CAC TCG-3*; primer 9, 5*-CTG GCA AGT CTG CAG
Forty-eight hours after rat cortical cells were plated in 96-well
GTG AC-3*; primer 10, 5*-CCA GCA TTC TTC TAT CGT TTC-
plates, growth factors, neutralizing antibody, or control serum were
3*; primer 11, 5*-GAG CTC GTT TCT CGT TGC AAG-3*; primer
added to each well. When TGF-b was added together with its neu-
12, 5*-TTG ACC GAC CTC CTG ATC AGG-3*; primer 13, 5*-
tralizing antibody, TGF-b and its neutralizing antibody were mixed
GGA AAG GGC TCA ACA CCT GCA-3*; primer 14, 5*-TGC ACT
and incubated for at least 30 min at room temperature before addi-
TGC AGG AGC GCA CGA T-3*; primer 15, 5*-TAC AGA CTG
tion to the culture. After additional culture of 72 hr, a 1/10 volume
GAG TCC CAG CAG-3*; primer 16, 5*-ATC ATA TTG GAA AGC
of 5 mg/ml MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tet-
TGT TCG AT-3*; primer 17, 5*-TCC GCA ACC TGG AGG AGA
razolium bromide, Dojindo Lab., Japan] was added to each well,
ACT G-3*; primer 18, 5*-GCA CTT ACA CGA CTT CAC CAC-
and the cells were incubated for 4 hr at 377C. The supernatant was 3*; primer 19, 5*-CGG GAT CCA TGA CCA TCC TTT TCC TTA
gently removed so as not to disturb the cells and the formazan. CTA-3*; primer 20, 5*-CGG AAT TCC TAT CTT CCC CTT TTA
Then 0.04 N HCl±isopropanol was then added to each well, and ATG GT-3*; primer 21, 5*-CGG GAT CCA TGT CCA TCT TGT
the cells were well solubilized by pipetting. The OD595 was mea- TTT ATG TG-3*; primer 22, 5*-GCT CTA GAT CAT GTT CTT
sured by microplate reader and normalized against OD650 . Data are CCG ATT TTT CT-3*. The primers 1 and 2 were for TGF-b type
expressed in terms of the ratios to control value. I receptor, 3 and 4 for TGF-b type II receptor, 5 and 6 for activin
type I receptor, 7 and 8 for activin type Ib receptor, 9 and 10 for
activin type II receptor, 11 and 12 for activin type IIb receptor, 13Immunocytochemistry and 14 for TGF-b1, 15 and 16 for TGF-b2, 17 and 18 for TGF-b3,
19 and 20 for BDNF, and 21 and 22 for NT-3, respectively. TheAfter incubated for indicated periods of time, primary cultured
cycling parameters of PCR for BDNF and NT-3 were 947C for 40cells were washed twice with TS buffer (50 mM Tris±HCl, pH
sec, 547C for 30 sec, and then 727C for 1 min for 20 and 30 cycles.7.4, 150 mM NaCl) and ®xed in 4% paraformaldehyde at room
Exactly the same amount of reverse-transcribed cDNA was sub-temperature for 30 min. Cells were further treated with acid±meth-
jected to PCR, and the linearity of PCR ampli®cation was ensuredanol containing 0.5% H2O2 at 47C for 5 min and rinsed for 10 min
(data not shown). The cycling parameters of PCR in Fig. 7 weretwice with TS, blocked at room temperature for 30 min in 20%
947C for 40 sec, 547C for 30 sec, and then 727C for 1 min for 32calf serum in TS, incubated at room temperature for 1 hr in anti-
cycles. PCR products were separated on 2% agarose gels.MAP-2 monoclonal antibody (Amersham) diluted 1:1000 in 10%
calf serum in TS, washed three times with TS, incubated in 1:500
dilution of biotinylated anti-mouse IgG (Vector Laboratories Inc.),
rinsed three times with TS, treated with ABC at room temperature Af®nity Crosslinking
for 30 min, rinsed three times with TS, and developed with DAB
An af®nity crosslinking experiment was performed as described(Sigma, 3,3*-diaminobenzidine tetrahydrochloride).
(Massague et al., 1987). Con¯uent cells were washed three times
with ice-cold binding buffer (128 mM NaCl, 5 mM KCl, 5 mM
MgSO4, 1.2 mM CaCl2, 50 mM Hepes, pH 7.5, 2 mg/ml BSA) andNorthern Blot Analysis
then incubated in the same buffer containing 100 pM of 125I-TGF-
b1 (Amersham) in the presence or absence of unlabeled TGF-b1Primary culture cells were treated with 10 ng/ml of TGF-b2 for
various times (0 or 30 min or 2, 4, or 24 hr). Total RNA was ex- (60 ng/ml) for 4 hr at 47C. The medium was removed, and the
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cells were washed four times with binding buffer followed by the but not in the entorhinal cortex, the piriform cortex, and the
addition of binding buffer without BSA. Then disuccinimidyl su- amygdaloid complex (Figs. 3A±3D). In comparison, TGF-b2
berate (DSS) (Pierce Chemical Co.) was added at a ®nal concentra- has been shown to be expressed in the cerebral cortices
tion of 0.14 mM, and the cells were incubated at 47C for 15 min. including the frontal, entorhinal, perirhinal, and piriform
The reaction was quenched by the addition of detachment buffer regions and in the amygdaloid complex and the hippocam-
(10 mM Tris±HCl, pH 7.4, 1 mM EDTA, 10% glycerol, 0.3 mM
pus (Poulsen et al., 1994). The collocalization of TGF-b2phenylmethylsulfonyl ¯uoride), and the cells were harvested by
and the type I receptors in neocortex strongly suggests thescraping, centrifuged at 15,000g for 2 min, and resuspended in solu-
regional interaction of the ligands and their receptors inbilization buffer (125 mM NaCl, 10 mM Tris±HCl, pH 7.4, 1 mM
differentiating neurons. In allocortex such as entorhinal andEDTA, 1% Triton-X 100, 0.3 mM phenylmethylsulfonyl ¯uoride).
After 40 min incubation, the soluble fraction was separated by piriform cortices, however, the exclusive expression of the
centrifugation at 15,000g for 15 min and subjected to 7.5±10% ligands argues the existence of another receptor system or
SDS±PAGE. The gels were dried and analyzed by Fuji Image Ana- alternatively that the ligands interact by remote neurons
lyzer (BAS 2000). via neural ®bers, as in the dopaminergic system (Poulsen
et al., 1994). It is also noteworthy that the type I receptors
were detectable at Day 14 in the dentate granular cells of
hippocampus and in the mitral cells of the olfactory bulbRESULTS
(Fig. 3E) where TGF-b2 and TGF-b3 were detected, respec-
tively (Poulsen et al., 1994).TGF-b Receptor Type I and Type II mRNAs Are
In the retina, all layers of retinal cells equally expressedDifferentially Expressed in Murine Embryos
TGF-b type I receptor but not type II receptor (Figs. 1C and
1D), suggesting that some neurons still expressed the typeAlthough TGF-bs have been shown to play an important
role in murine development (Akhurst et al., 1990; Millan I receptors even at their terminally differentiated state. In
nonneuronal tissues of murine embryos, type I receptoret al., 1991; Pelton et al., 1991; Schmid et al., 1991; Dickson
et al., 1993), the developmental expressions of their recep- mRNA was also exclusively detected in the developing kid-
ney (Fig. 1A) where the in situ signals were localized intors have not yet been well characterized. In order to study
how TGF-b type I and type II receptors are regulated in the ductal structures (data not shown). In vertebral and mandib-
ular bones (Fig. 1A), the strong signal intensities detecteddevelopment of murine embryos, we determined the spatial
and temporal expressions by in situ hybridization. For all in situ were speci®cally localized to osteoblasts microscopi-
cally. In the nasal epithelia and tooth bud of murine em-the in situ hybridizations described below, the speci®city
was con®rmed by control experiments using the sense bryos (Figs. 1C and 1D), the type I and type II receptors
were both expressed at high levels. H&E staining of in situprobes for TGF-b type I and type II receptors (data not
shown). In the Day 16 p.c. embryo, the type I and type II samples of adjacent sections revealed that nasal epithelial
cells expressed both TGF-b type I and type II receptors, butreceptors showed completely distinct speci®cities of expres-
sion (Figs. 1A and 1B). In the development of the nervous that cells in the outer layer dominantly expressed the type
I receptors, whereas those in the inner layer primarily ex-system, the type I receptors were highly expressed in telen-
cephalon and diencephalon, but less intensely in mesen- pressed the type II receptors (Figs. 1A and 1B). In the tooth
bud, however, both receptors were equally and speci®callycephalon, hindbrain, and spinal cord, whereas the signals
of type II receptors were completely negative (Figs. 1A and expressed in odontoblasts (Figs. 1A and 1B).
1B). The cells that express the type I but not type II receptors
were also detected in the kidney, retina, and vertebral bone
TGF-b Serves as a Survival Factor for Neonate(Figs. 1A and 1B) and this speci®city continued to be de-
Cortical Neurons in Vitrotected in neonatal development (Figs. 1C and 1D).
In the neuroepithelium of the Day 14 p.c. embryo, the One of the intriguing results of the in situ hybridization
is the intensive expression of the type I receptors in thetype I receptor mRNA was initially localized to differentiat-
ing neurons in the marginal zone (Fig. 2A). In the neuroepi- developing cerebral cortices. This ®nding intimates the pos-
sible involvement of TGF-b signaling in the developmentthelium of the Day 16 p.c. embryo, the type I receptor
mRNA was up-regulated and dominantly localized in the of the cerebral cortex.
To assess the biological function of TGF-b and otherpostmitotic neurons of primordial cortex, whereas the sig-
nal was less intense in ventricular and subventricular zones members of the TGF-b superfamily in cortical develop-
ment, a neuronal culture was prepared from Day 16 p.c. rat(Figs. 2A and 2B), suggesting that neuronal precursor cells
start to express TGF-b type I receptors after the mitosis or cerebral cortex and was maintained in serum-free media or
media containing less than 1.0% serum as described (Ghoshalternatively, when they migrate. In the neonatal stage, the
type I receptor continues to be detected in cortical neurons et al., 1994). The cellular population was determined by
immunohistochemical staining with anti-MAP-2 mono-at Day 3 (Figs. 2C, 3A, and 3B) and Day 7 (Figs. 3C and 3D),
but is barely detectable at Day 14 (Figs. 3E and 3F) when clonal antibody, showing that more than 98% were esti-
mated as neurons. However, very few glial cells or ®bro-the laminar structure of cerebral cortex is well organized.
In early neonatal stages, the type I receptors were detected blasts were detectable by staining with anti-GFAP mono-
clonal antibody (data not shown). At Day 2, cells wereonly in the frontal, anterior, central, and insular cortices,
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FIG. 1. TGF-b type I and type II receptor mRNA expression in murine development. TGF-b type I (A) and type II receptor (B) mRNA
expression in the sagittal section of a Day 16 p.c. murine embryo. TGF-b type I (C) and type II receptor (D) mRNA expression in the
coronal section of Day 3 neonatal maxilla. Speci®c expression was con®rmed by control in situ hybridization using sense probes for both
TGF-b type I and type II receptors (data not shown). Abbreviations: ge, ganglionic eminence; ki, kidney; lu, lung; nc, nasal cavity; ol,
olfactory bulb; rt, retina; tb, tooth bud; te, telencephalon; vt, vertebral bone. Magni®cation: 15 in A±D.
treated with TGF-b1, -b2, activin, or follistatin, an endoge- showed that anti-TGF-b neutralizing antibody signi®cantly
inhibited the survival of cortical neurons in a dose-depen-nous inhibitor for activin (Eto et al., 1987), and the survival
of neurons was examined by MTT assay at Day 5 (Mossman, dent manner (Fig. 4B), suggesting that endogenous TGF-bs
play an important role in the survival of neurons in the1983). The results showed that the survival of cultured neu-
rons was not signi®cantly affected by the addition of these primary culture system. An addition of TGF-b1 yielded es-
sentially the same result as that of TGF-b2 (data not shown).factors even at high doses (Fig. 4A). We then asked whether
the blocking of the TGF-b signaling pathway has any effect Since TGF-b2 but not TGF-b1 has been shown to be ex-
pressed in neonatal cerebral cortices (Poulsen et al., 1994),on the survival of neurons by the use of a speci®c neutraliz-
ing antibody (see Materials and Methods). The results TGF-b2 was used in the following experiments. Convinc-
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FIG. 2. Cellular localization of TGF-b type I receptor mRNA in developing cerebral cortex. TGF-b type I receptor mRNA expression in
cerebral cortex of a Day 14 p.c. murine embryo (A), a Day 16 p.c. embryo (B), and of a Day 3 murine neonate (C). In situ sections were
counterstained with H&E staining. Dark-®eld in situ images were superimposed with bright-®eld photomicrographs. Abbreviations: MgZ,
marginal zone; MZ, mantle zone; EZ, ependymal zone; PrC, Primordial cortex; CC, cerebral cortex; WM, white matter; NSZ, neocortical
subventricular zone. Original magni®cations: A, 1500; B, 1300; C, 1100.
ingly, the addition of exogenous TGF-b2 (30 ng/ml) partially Treatment with 10 ng/ml activin A or with 10 ng/ml fol-
listatin had no visible effects on the morphology of culturedrescued neurons from antibody-induced cell death in the
assay system (Fig. 4B). To con®rm the speci®city of the cells even after 7 days' incubation (data not shown), nor on
control or TGF-b2 treated cultures.signal further, we also tested the possibility that the increas-
ing amount of TGF-b2 could restore neuron survival. As
shown in Fig. 4C, TGF-b2 was found to reverse the inhibi-
The Trophic Effect of TGF-b2 for Cortical Neuronstory effect of a neutralizing antibody in a dose-dependent
May Be Mediated by the Regulation of bcl-2manner. We then studied the morphological changes of cul-
tured neurons after the addition of TGF-b or a neutralizing In order to analyze how TGF-b2 exerts its trophic effect
on cultured cortical neurons, we asked whether TGF-b2antibody. As a control, rat primary cortical neurons were
cultured with 0.4% normal rabbit serum for 3 days (Fig. 5A) could up-regulate the expression of neurotrophins, BDNF
and NT-3, because they were recently found to play an im-or for 7 days (Fig. 5D), followed by immunocytochemical
staining with anti-MAP-2 monoclonal antibody. More than portant role in the regulation of cortical neurogenesis
(Ghosh and Greenberg, 1995). RT±PCR experiments using98% of cultured cells were stained with anti-MAP-2, which
con®rmed their neuronal population and their viability at speci®c primers for BDNF or NT-3 showed that these neuro-
trophins were expressed in cultured neurons and that TGF-Days 3 and 7. Similar results were obtained in cultures
treated with 0.4% control serum supplemented with 10 ng/ b2 or its neutralizing antibody did not affect their expres-
sion levels up to 24 hr (Figs. 6A and 6B).ml TGF-b2 for 3 days (Fig. 5B) or for 7 days (Fig. 5E). On the
other hand, treatment with TGF-b neutralizing antibody (1/ We then asked whether TGF-b2 regulates the expression
of bcl-2, which is involved in the protection of a variety of250 concentration, including 0.4% serum) for 3 days (Fig.
5C) or for 7 days (Fig. 5F) resulted in the progressive dropout cells including neurons against certain types of cell death
(Hochenberg et al., 1990; Garcia et al., 1992; Prehn et al.,of neurons with blebbing and severe fragmentation of neu-
rites. Morphological changes in cultured neurons treated 1994). Northern blot analysis probed by bcl-2 cDNA showed
that bcl-2 mRNA is expressed in cultured neurons and awith the neutralizing antibody correlated well with the re-
sults of MTT assay (data not shown), suggesting that TGF- neutralizing antibody for TGF-b (1/250 concentration) sig-
ni®cantly reduced its expression after 2, 4, and 24 hr ofb is required for the survival and maintenance of differenti-
ating and differentiated neurons with neurite extensions. incubation (Fig. 6C). RT±PCR with speci®c bcl-2 primers
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FIG. 3. TGF-b type I receptor mRNA expression during the development of neonatal brain. TGF-b type I receptor mRNA expression
was analyzed by in situ hybridization in sagittal and coronal sections of Day 3 (A, B), Day 7 (C, D), and Day 14 (E, F) murine neonatal
brains. Abbreviations: bs, brain stem; cb, cerebellum; cc, cerebral cortex; dg, dentate gyrus; hip, hippocampus; ic, inferior colliculus; ob,
olfactory bulb; sc, superior colliculus; st, striatum; th, thalamus. Magni®cations: A, 110; B, 113; C, 18; D, 111; E, 18; F, 17.
gave similar results (data not shown), con®rming the down- three major bands were crosslinked with 125I-TGF-b1. From
their molecular size, a band of 70 kDa and a broad band ofregulation of bcl-2 by the neutralizing antibody. The stimu-
lation with TGF-b2, however, did not increase the level 250±300 kDa were concluded to be the type I and type III
of bcl-2 expression (Fig. 6C), suggesting that endogenously receptors, respectively (Fig. 7A, RI and RIII; Massague et
secreted TGF-bs constitutively maintained the basal ex- al., 1987). These bands were competitively, albeit partially,
pression of bcl-2 so that the addition of exogenous TGF-b2 inhibited when cold TGF-b was included in a crosslinking
failed to up-regulate its expression. This result is consistent reaction (Figs. 7A and 7B; right lanes). However, we failed
with the data obtained by MTT assay (Fig. 4). to identify the type II receptors (80±85 kDa) in crosslinking
experiments (Figs. 7A and 7B). Rather, we identi®ed another
TGF-b binding molecule with molecular weight of 140±
Three Isoforms of TGF-b and TGF-b Type I 160 kDa (designated RX in Figs. 7A and 7B). Since this
Receptor but Not Type II Receptor Are Detected in molecule was as well competitively inhibited by cold TGF-
Primary Neonate Cortical Neurons
b (Figs. 7A and 7B), this may also be a component of the
TGF-b receptor complex.Since the in vitro culture experiments indicated the exis-
To further con®rm the expression of signaling receptorstence of functional signaling receptors in primary cortical
in primary cortical neurons, we performed RT±PCR withneurons (Fig. 4), we then characterized the receptor mole-
speci®c primers. The transcripts of TGF-b type I receptor,cules on the surface of cultured neurons by af®nity cross-
linking with 125I-TGF-b1. As shown in Figs. 7A and 7B, activin type I/Ib receptors, and activin type II/IIb receptors
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were successfully ampli®ed (Fig. 7C). The transcripts of
TGF-b type II receptors failed to be ampli®ed from the same
mRNA template, while the same primers can detect the
type II receptor transcripts in a control RT±PCR using an
adult lung mRNA as a template (Fig. 7D). From these experi-
ments, we conclude that the expression of TGF-b type II
receptors is virtually absent in cultured cortical neurons.
As to the expression of ligands in cultured neurons, we
investigated the expression of TGF-bs by RT±PCR (Fig. 7E).
Based on the results of in vitro culture expreriments with
a neutralizing antibody for TGF-b (Fig. 4), we expected that
TGF-bs were secreted by cultured neurons. As shown in
Fig. 7E, three isoforms of TGF-bs, TGF-b1, -b2, and -b3,
were ampli®ed by RT±PCR, suggesting that cultured corti-
cal neurons endogenously secrete TGF-bs which could
maintain bcl-2 expression for their survival.
DISCUSSION
Disproportional Expressions of TGF-b Type I and
Type II Receptors during Murine Development
In the present study, we compared for the ®rst time the
spatial and temporal expressions of TGF-b type I and type
II receptors in adjacent sections of developing murine em-
bryos. According to the current model, TGF-b type I recep-
tor is required for the type II receptor to signal, whereas the
type II receptor is needed for the type I receptor to bind to
its ligand, and both forms of receptors are indispensable for
eliciting biological responses of TGF-b (Wrana et al., 1992,
1994; Attisano et al., 1993; Franzen et al., 1993; Bassing
et al., 1994). In this respect, one would expect that both
molecules have a similar expression pattern. Actually, in
some developing organs including the tooth bud and mesen-
chymal cells, both the type I and type II receptors were
expectedly coexpressed. Our in situ result on TGF-b type
II receptors con®rmed previous results which showed the
mesenchymal expression of the type II receptors (Lawler et
al., 1994; Roelen et al., 1994). Although both receptors wereFIG. 4. Effect of TGF-b on the survival of cortical neurons in
expressed in nasal epithelia, the expression patterns of twovitro. (A) Survival of Day 16 p.c. rat embryonal cortical neurons
receptors did not overlap microscopically (Figs. 1C and 1D).treated with increasing amounts of TGF-b2, activin A, and fol-
listatin for 3 days. Bars represent the mean{ SE for each condition. Disproportional expression of TGF-b type I and type II re-
None of these factors signi®cantly affected neuron survival. (B) ceptors in these tissues might then have a physiological role
Survival of cortical neurons after the addition of a series of dilution in the local regulation of TGF-b signals.
ratios of an anti-TGF-b neutralizing antibody (open circle). Treat- Intriguingly, in late gestational stages, differentiating
ment with the antibody signi®cantly reduced neuron survival in a neurons and retinal cells expressed TGF-b type I receptors
dose-dependent manner. An incubation of the antibody with 30 without any detectable level of the type II receptors. This
ng/ml TGF-b2 partially rescued neuron survival (closed circle). To
clearly indicates that these receptors are transcriptionallynormalize the serum concentration in each culture, control serum
regulated in a distinct manner. It is conceivable that in(normal rabbit serum) was included at a ®nal concentration of 1%.
these organs, predominant receptor species on the cell sur-(C) Dose-dependent rescue of neuron survival by exogenous TGF-
face represent the type I receptors while the type II recep-b2. Dilution ratio of the neutralizing antibody adopted in this ex-
periment was 1/500 (®nal serum concentration was 0.2%). Serum tors may be absent or expressed at very low levels. An-
concentration of the control culture (white box) was also adjusted other explanation is that an alternate form of TGF-b type
to 0.2% with control serum. Data are the mean { SE of triplicate II receptors are expressed, as suggested by the data pre-
experiments. sented in Fig. 7.
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FIG. 5. Effects of TGF-b and its neutralizing antibody on cultured cortical neurons in vitro. (A, B, and C) Photomicrographs of cultured
cortical neurons incubated for 3 days with 0.4% control serum (A), 0.4% control serum with 10 ng/ml TGF-b2 (B), and diluted (1/250)
anti-TGF-b neutralizing antibody (®nal serum concentration was 0.4%) (C), respectively. (D, E, and F) Cultures incubated for 7 days with
0.4% control serum, 0.4% control serum with TGF-b2 (10 ng/ml), and antibody (1/250), respectively. All these cultures were stained with
anti-MAP-2 monoclonal antibody. Magni®cation: 1500.
TGF-b Is a Survival Factor for Cortical Neurons in bcl-2 expression. Probably, in the present cultured cells,
Vitro: Correlation with TGF-b Type I Receptor endogenous TGF-b stimulates the bcl-2 expression required
Expression for neuronal survival. Dysregulation of this autoregulatory
pathway by the neutralizing antibody may lead to the de-
An intensive expression of TGF-b type I receptors but not
crease of bcl-2 and subsequent cell death.detectable level of the type II receptors in developing cerebral
In our cortical culture system, activin or follistatin, ancortices prompted us to study whether TGF-b has any effect
inhibitor of activin, failed to affect the survival of culturedon cortical neurons in vitro. To account for this, we studied
neurons (Fig. 4) in spite of the fact that all known activinthe biological activity of TGF-b in rat primary cortical cul-
receptors were ampli®ed by RT±PCR (Fig. 7). This resultture. An anti-TGF-b neutralizing antibody signi®cantly re-
suggested that activin serves as a survival factor for dopa-duced the survival of cortical neurons, indicating that TGF-
minergic neurons (Krieglstein et al., 1995), but not for corti-b was a survival factor for cultured cortical neurons. The
cal neurons, and may play a distinct role in cortical neurons.speci®city of the trophic effect was con®rmed by reversing
In the primary cortical neurons, TGF-b type I and type IIIthe inhibitory effects of the antibody by TGF-b2.
receptors were readily detected by crosslinking experimentsAs to neuronal apoptosis, it has been shown that the over-
but TGF-b type II receptors could not be identi®ed. In addi-expression of bcl-2 protects neuronal cell death (Garcia et
tion, the fact that TGF-b type II receptor mRNA could notal., 1992). In addition, TGF-b has been shown to induce bcl-
be detected by RT±PCR as well indicated that its expression2 in hippocampal neurons and thereby confers resistance to
is very low or virtually absent. This raises questions as toCa2/-induced cell death (Prehn et al., 1994). In our cortical
how TGF-b is crosslinked to TGF-b type I receptors andculture system, an anti-TGF-b neutralizing antibody sig-
whether TGF-b can transduce its signal via a very low levelni®cantly reduced the bcl-2 mRNA level, which correlated
of heterooligomeric complex or alternatively by a dissimilarwell with neuronal cell death, while the exogenous TGF-
mechanism.b2 did not affect bcl-2 expression. This effect was observed
Since TGF-b2 is a predominantly expressed isoformas early as 2 hr after the addition of the neutralizing anti-
among TGF-bs in the developing cerebral cortices (Flandersbody and remained up to 24 hr. The rapid time course in
et al., 1991; Poulsen et al., 1994), TGF-b2 is likely to be athe change of the bcl-2 mRNA level prior to any detectable
physiological ligand for cortical neurons. Spatial and tempo-sign of cell death strongly argues that the survival effect of
TGF-b is mediated, at least in part, by the maintenance of ral expressions of TGF-b type II receptors in vivo correlate
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ral network formation. In this respect, it is intriguing to
note that several members of the TGF-b superfamily has
been reported to function as survival factors for various
FIG. 6. An anti-TGF-b neutralizing antibody down-regulates the
expression of bcl-2 in cultured cortical neurons. BDNF (A), NT-3
(B), and bcl-2 (C) mRNAs were investigated by RT±PCR (A, B) or
RNA blot analysis (C). Rat cortical neurons were treated for 0.5,
2, 4, 24 hr with TGF-b, vehicle, or anti-TGF-b neutralizing anti-
body and total RNAs were prepared. BDNF (A) and NT-3 (B)
mRNAs were investigated by RT±PCR. bcl-2 mRNAs were investi-
gated by RNA blot analysis using 10 mg of total RNA per lane (C).
The same ®lter was rehybridized with EF-1a (C).
well with that of TGF-b1, but not TGF-b2 or -b3 (Fig. 1;
Pelton et al., 1991; Unsicker et al., 1991; Lawler et al.,
1994). Our observations presented in this study are consis-
tent with the previous notion that there might be an uniden- FIG. 7. Expression of TGF-bs and their receptors in neuronal culture
in vitro. (A and B) Af®nity crosslinkingwith 125I-TGF-b1 was performedti®ed type II receptor component which is more speci®c to
as described under Materials and Methods, and an equal volume ofTGF-b2 (Lawler et al., 1994). The identi®cation and charac-
soluble fraction was separated on 10% SDS±PAGE (A) or on 7.5%terization of the receptor complex in the cerebral cortex,
SDS±PAGE (B), respectively. Three bands termed RI, RX, and RIII wereretina, and other developing tissues may further clarify the
speci®cally crosslinked with 125I-TGF-b. Speci®c binding was con-relationship between the isoforms and speci®cities in bio-
®rmed by partial competition with 60 ng/ml cold TGF-b1 (the rightlogical activities of TGF-bs.
lane, termed C, of each panel). The positions corresponding to molecu-
lar weight markers (MW) electrophoresed on parallel lanes are shown.
(C) Expression of TGF-b or activin receptor mRNA in rat cultured
cortical neurons detected by RT±PCR. Each pair of oligonucleotidesRole of TGF-b and Its Receptors in the
used in PCR (see Materials and Methods) was designed not to crossDevelopment of the Central Nervous System
the other receptor molecules. Speci®c signals were indicated by an
arrow. All of the reported TGF-b and activin receptors except for typeIn the cerebral cortex, the expression of TGF-b type I
II TGF-b receptor were expressed in cultures. (D) Primers for TGF-breceptor was stronger in postmitotic neurons of the mar-
type II receptor worked in the control RT±PCR using an adult lungginal zone, but weak or absent in immature precursor cells
mRNA as a template (/RT). No signal was detected in the lung mRNA
of the ventricular zone (Fig. 2), suggesting that receptor ex- withought reverse transcription (0RT). (E) Expressionsof three isoforms
pression may be associated with postmitotic neuronal of TGF-bs in cultured cortical neurons detected by RT±PCR. Each pair
events such as neuronal migration, differentiation, and neu- of oligonucleotides used in PCR was designed not to cross the other
isoforms of TGF-bs. Speci®c signals were indicated by an arrow.
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(1994). A transforming growth factor b type I receptor that signalsneural cells. Activin was shown to promote the survival of
to activate gene expression. Science 263, 87±89.teratocarcinoma cell lines in the absence of retinoic acid,
Carcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L.,which induced the teratocarcinoma cell to a neuronal lin-
Attisano, L., and Massague, J. (1994). Type I receptors specifyeage (Schubert et al., 1990). GDNF was identi®ed as a tro-
growth-inhibitory and transcriptional responses to transformingphic factor for midbrain dopaminergic neurons (Lin et al.,
growth factor b and activin. Mol. Cell. Biol. 14, 3810±3821.
1993). TGF-b has been shown to have a trophic action on Chalazonitis, A., Kalberg, J., Twardzik, D. R., Morrison, R. S., and
DRG sensory neurons (Chalazonitis et al., 1992). Recently, Kessler, J. A. (1992). Transforming growth factor b has neuro-
TGF-bs were also shown to possess a trophic activity for trophic actions on sensory neurons in vitro and is synergistic
midbrain dopaminergic neurons and hippocampal neurons with nerve growth factor. Dev. Biol. 152, 121±132.
in vitro (Poulsen et al., 1994; Prehn et al., 1994; Krieglstein Chomzynski, P., and Sacci, N. (1987). Single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-chloroformet al., 1995). Here we provide the ®rst evidence that TGF-
extraction. Anal. Biochem. 162, 156 ±159.b has neurotrophic activity for cortical neurons in vitro. In
Dickson, M. C., Slager, H. G., Duf®e, E., Mummery, C. L., andaddition, we showed that TGF-bs were expressed in the
Akhurst, R. J. (1993). RNA and protein localizations of TGF-b2nearly pure neuronal culture, suggesting that TGF-b exerts
in the early mouse embryo suggest an involvement in cardiacits neurotrophic action in an autocrine or paracrine manner.
development. Development 117, 625±639.
The colocalizing expressions of both ligands and receptors
Ebner, R., Chen, R.-H., Shum, L., Lawler, S., Zioncheck, T. F., Lee,
in developing cerebral cortices also support a neurotrophic A., Lopez, A. R., and Derynck, R. (1993). Cloning of a type I TGF-
role of TGF-b during cortical development in vivo. It would b receptor and its effect on TGF-b binding to the type II receptor.
then be interesting to know how other neurotrophic factors Science 260, 1344±1348.
such as BDNF, NT-3, and NT-4/5 cooperate with TGF-b2 Eto, Y., Tsuji, T., Takezawa, M., Takano, S., Yokogawa, Y., and
to contribute to the development of cortical structure or Shibai, H. (1987). Puri®cation and characterization of erythroid
differentiation factor (EDF) isolated from human leukemia cellthe formation of cortical neural networks.
line THP-1. Biochem. Biophys. Res. Commun. 142, 1095±1103.In summary, we showed that TGF-b acts as a survival
Flanders, K. C., Ludecke, G., Engels, S., Cissel, D. S., Roberts, A. B.,factor for cortical neurons in which TGF-b type I receptors
Kondaiah, P., Lafyatis, R., Sporn, M. B., and Unsicker, K. (1991).are expressed but the type II receptors are virtually absent.
Localization and actions of transforming growth factor-betas inSince TGF-b2 appears to be a physiological ligand in the
the embryonic nervous system. Development 113, 183 ±191.developing cerebral cortices, TGF-b2 and TGF-b type I re-
Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P.,ceptors, together with yet unidenti®ed receptor molecules,
Heldin, C., and Miyazono, K. (1993). Cloning of a TGF-b type I
may be involved in TGF-b signaling during cortical develop- receptor that forms a heteromeric complex with the TGF-b type
ment. Further study is needed to clarify the wide range of II receptor. Cell 75, 681±692.
biological activities and the diverse signaling pathways of Garcia, I., Martinou, I., Tsujimoto, Y., and Martinou, J. C. (1992).
TGF-b during the developmental process. Prevention of programmed cell death of sympathetic neurons by
the bcl-2 proto-oncogene. Science 258, 302±304.
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